Envestnet Asset Management Inc. Increases Holdings in U.S. Physical Therapy, Inc. $USPH

Envestnet Asset Management Inc. boosted its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 9.4% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 346,160 shares of the company’s stock after purchasing an additional 29,671 shares during the period. Envestnet Asset Management Inc. owned about 2.28% of U.S. Physical Therapy worth $27,070,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of USPH. Copeland Capital Management LLC grew its holdings in shares of U.S. Physical Therapy by 8.9% during the 2nd quarter. Copeland Capital Management LLC now owns 888,735 shares of the company’s stock worth $69,499,000 after acquiring an additional 72,463 shares during the period. Bahl & Gaynor Inc. grew its holdings in shares of U.S. Physical Therapy by 32.6% during the 1st quarter. Bahl & Gaynor Inc. now owns 345,003 shares of the company’s stock worth $24,964,000 after acquiring an additional 84,878 shares during the period. GW&K Investment Management LLC grew its holdings in shares of U.S. Physical Therapy by 8.9% during the 1st quarter. GW&K Investment Management LLC now owns 344,390 shares of the company’s stock worth $24,920,000 after acquiring an additional 28,203 shares during the period. Northern Trust Corp grew its holdings in shares of U.S. Physical Therapy by 4.7% during the 1st quarter. Northern Trust Corp now owns 274,117 shares of the company’s stock worth $19,835,000 after acquiring an additional 12,292 shares during the period. Finally, Nuveen LLC purchased a new position in shares of U.S. Physical Therapy during the 1st quarter worth approximately $8,702,000.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on USPH. JPMorgan Chase & Co. began coverage on U.S. Physical Therapy in a report on Thursday, September 18th. They set an “overweight” rating and a $110.00 target price on the stock. Wall Street Zen downgraded U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Sunday, September 21st. Barrington Research reiterated an “outperform” rating and set a $103.00 target price on shares of U.S. Physical Therapy in a report on Friday, October 24th. Weiss Ratings restated a “hold (c)” rating on shares of U.S. Physical Therapy in a report on Wednesday, October 8th. Finally, Zacks Research upgraded shares of U.S. Physical Therapy to a “hold” rating in a report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $110.25.

U.S. Physical Therapy Stock Performance

U.S. Physical Therapy stock opened at $86.92 on Tuesday. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.30. The company has a market capitalization of $1.32 billion, a P/E ratio of 37.96, a PEG ratio of 4.41 and a beta of 1.48. The stock’s 50 day moving average is $85.59 and its 200 day moving average is $79.75. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $101.19.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Tuesday, August 22nd. The company reported $0.90 earnings per share (EPS) for the quarter. The business had revenue of $140.66 million for the quarter. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%. On average, equities research analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 12th. Investors of record on Friday, August 22nd were given a $0.45 dividend. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $1.80 annualized dividend and a yield of 2.1%. U.S. Physical Therapy’s dividend payout ratio is 78.60%.

Insiders Place Their Bets

In related news, COO Graham D. Reeve sold 1,792 shares of the company’s stock in a transaction that occurred on Monday, August 11th. The stock was sold at an average price of $86.57, for a total value of $155,133.44. Following the transaction, the chief operating officer directly owned 22,246 shares of the company’s stock, valued at approximately $1,925,836.22. This represents a 7.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Christopher J. Reading sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $83.53, for a total value of $167,060.00. Following the completion of the transaction, the chief executive officer directly owned 114,088 shares in the company, valued at $9,529,770.64. This trade represents a 1.72% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 6,853 shares of company stock worth $581,406 in the last three months. Corporate insiders own 2.00% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.